Medicenna Therapeutics Corp. (MDNAF) — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2022)

-CA$10.0M

Total Assets (FY2022)

CA$36.4M

Total Equity (FY2022)

CA$29.5M

Cash Flows from Operating Activities (FY2022)

-$22.7M

Source: Medicenna Therapeutics Corp. 20-F filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.